483
Hanacos Co., Ltd.Hanacos Co., Ltd. – FDA 483, Nov 30, 2023
Record Details
Hanacos Co., Ltd., an OTC drug product manufacturer in Hoengseong, Korea, was cited for multiple significant deficiencies during an FDA inspection. The firm's quality system was found to be severely lacking, with repeat observations concerning stability programs, employee training, annual product reviews, cleaning validation, and equipment qualification. Additionally, the firm failed to perform critical microbial testing and validate its test methods according to U.S. cGMP regulations.
View Company Profile
ID · e791a085-bec4-41c8-9743-f1bdf81b7e1a
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.